Patient ALMA_9_BM (60 + years, male; coverage 18.12x), diagnosed with MDS-NOS (trisomy 8, 15–20% blasts), was accurately predicted as MDS-related secondary myeloid, confirmed by RUNX1/RUNX1-AS1 mutations. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.